1. Home
  2. Medical Devices & Consumables
  3. Global Blood Screening Market worth USD 4 billion by 2024, at a CAGR – 9%

Global Blood Screening Market worth USD 4 billion by 2024, at a CAGR – 9%

Publication Month: Jan 2020 | No. of Pages: 128 Published By: Reports Intellect
Single User License: US $ 3500
Corporate User License: US $ 6500

Market Definition

The Global Blood Screening market is estimated to reach $4 billion by 2024 from $1.9 billion in 2019; growing at a CAGR of 9.1% from 2019 to 2024.

Blood Screening is used to detect the infection in the blood in order to prevent the release of infected blood and its components.

The main purpose of the Blood Screening technique is to assure the safety of blood units.

Market Dynamics

The Global Blood Screening market is primarily driven by factors such as the increasing ratio of infectious diseases and newer pathogens, a rise in blood donation, a rise in awareness.  

Market Segmentation

The Global Blood Screening market is mainly classified based on product and service, by technology, by end-user, and by region.

Based on the Product & Service segment, the market is categorized into Reagents & Kits, NAT Reagents & Kits (Enzymes and Polymerases, Standard & Controls, Probes & Primers, (Buffers, Nucleotides, and Solution), Labeling & Detection Reagents), Elisa Reagents & Kits (Immunosorbents, Controls, Conjugates, Substrates, Sample Diluents & Wash Solutions), Other Reagents & Kits, Instruments, Outright Purchase, Rental Purchase, Software & Services. Among them, reagents & kits sub-segment dominated the market.

Technology is further segmented into NAT, ELISA, rapid tests, western blot assays, and NGS. The NAT segment contributed the majority of the share driven by factors such as, due to rise in blood donations and the rise in adoption of NAT technology due to its sensitivity.

On the basis of the end-user, the market is further categorized into Blood Banks and Hospitals.

 

Regional Analysis

Based on geography, the global Blood Screening market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is categorized into China, Japan, India, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

Among all the regions, North America generated the highest revenue and is likely to continue its dominance over the forecast period. The high growth in the region is attributed due to the increasing ratio of infectious diseases and newer pathogens, rise in blood donation, rise in the awareness, growing infrastructure. Reports Intellect Analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Competitive Landscape

Key players operating in the Blood Screening market include Grifols, F. Hoffmann-La Roche, Abbott Laboratories, Bio-Rad, Becton (Dickson & Company), Danaher Corporation, Ortho Clinical Diagnostics, Siemens Healthineers, Thermo Fisher Scientific, Diasorin, GE Healthcare, Merck KGaA, PerkinElmer, Bio-Techne, GFE, Trinity Biotech, J. Mitra Diagnostics Pvt. Ltd.

 

 

Blood Screening Market Key Segments:

By Product & Service

  • Reagents & Kits
  • NAT Reagents & Kits

(Enzymes & Polymerases, Standards & Controls, , Probes & Primers, Buffers, Nucleotides, and Solution, Labeling & Detection Reagents)

  • Elisa Reagents & Kits

( Immunosorbents, Controls, Conjugates, Substrates, Sample Diluents & Wash Solutions)

  • Other Reagents and Kits
  • Instruments
  • Outright Purchase
  • Rental Purchase
  • Software & Services

By Technology

  • NAT
  • Transcription-Mediated Amplification
  • Real-time Polymerase Chain Reaction
  • ELISA
  • Chemiluminescent Immunoassay
  • Fluorescent Immunoassay
  • Fluorescent Immunoassay
  • Colorimetric Immunoassay
  • Rapid Tests
  • Western Blot Assays
  • NGS

By End-User

  • Blood Banks
  • Hospitals

By Region

  • North America
  • The U.S.A
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • Italy
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • GCC Countries
  • Egypt
  • South Africa
  • Rest of Middle East & Africa

 

Table of Contents

 

1 Market Overview

1.1 Blood Screening Introduction

1.2 Market Analysis by Product

1.2.1 Overview: Global Blood Screening Revenue by Product: 2017 VS 2019 VS 2024

1.2.2 Reagents 1.2.3 NAT Reagents

1.2.3.1 Enzymes & Polymerases

1.2.3.2 Standards & Controls

1.2.4 ELISA Reagents

1.2.4.1 Immunosorbents

1.2.4.2 Controls  

1.2.4.3 Conjugates

1.2.4.4 Substrates

1.2.4.5 Sample Diluents

1.2.5 Other Reagents

1.2.6 Instruments

1.2.7 Outright Purchase

1.2.8 Rental Purchase

1.2.9 Software & Services

 

1.3 Market Analysis by Technology

 

1.3.1 Overview: Global Blood Screening Revenue by Technology: 2017 VS 2019 VS 2024

1.3.2 NAT

1.3.3 Transcription-Mediated Amplificatio

1.3.4 Real-time Polymerase Chain Reaction

;1.3.6 Chemiluminescent Immunoassay

1.3.10 Western Blot Assays

1.3.11 NGS 

 

1.4 Market Analysis by End User

 

1.4.1 Overview: Global Blood Screening Revenue by End User: 2017 VS 2019 VS 2024

 

1.4.2 Blood Banks

 

1.4.3 Hospitals

1.5 Overview of Global Blood Screening Market

 

1.5.1 Global Blood Screening Market Status and Outlook (2017-2024)

 

1.5.2 North America (United States, Canada and Mexico)

 

1.5.3 Europe (Germany, France, United Kingdom, Russia and Italy)

 

1.5.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

 

1.5.5 South America, Middle East & Africa

 

1.6 Market Dynamics

 

1.6.1 Market Opportunities

 

1.6.2 Market Risk

 

1.6.3 Market Driving Force

 

2 Manufacturers Profiles

 

2.1 Grifols

 

2.1.1 Grifols Details

 

2.1.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis

 

2.1.3 Grifols SWOT Analysis

 

2.1.4 Grifols Product and Services

 

2.1.5 Grifols Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.2 Hoffmann-La Roche

 

2.2.1 Hoffmann-La Roche Details

 

2.2.2 Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis

 

2.2.3 Hoffmann-La Roche SWOT Analysis

 

2.2.4 Hoffmann-La Roche Product and Services

 

2.2.5 Hoffmann-La Roche Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.3 Abbott Laboratories

 

2.3.1 Abbott Laboratories Details

 

2.3.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

 

2.3.3 Abbott Laboratories SWOT Analysis

 

2.3.4 Abbott Laboratories Product and Services

 

2.3.5 Abbott Laboratories Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.4 Bio-Rad

 

2.4.1 Bio-Rad Details

 

2.4.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis

 

2.4.3 Bio-Rad SWOT Analysis

 

2.4.4 Bio-Rad Product and Services

 

2.4.5 Bio-Rad Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.5 Becton (Dickinson & Company)

 

2.5.1 Becton (Dickinson & Company) Details

 

2.5.2 Becton (Dickinson & Company) Major Business and Total Revenue (Financial Highlights) Analysis

 

2.5.3 Becton (Dickinson & Company) SWOT Analysis

 

2.5.4 Becton (Dickinson & Company) Product and Services

 

2.5.5 Becton (Dickson & Company) Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.6 Danaher Corporation

 

2.6.1 Danaher Corporation Details

 

2.6.2 Danaher Corporation Major Business and Total Revenue (Financial Highlights) Analysis

 

2.6.3 Danaher Corporation SWOT Analysis

 

2.6.4 Danaher Corporation Product and Services

 

2.6.5 Danaher Corporation Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.7 Ortho Clinical Diagnostics

 

2.7.1 Ortho Clinical Diagnostics Details

 

2.7.2 Ortho Clinical Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis

 

2.7.3 Ortho Clinical Diagnostics SWOT Analysis

 

2.7.4 Ortho Clinical Diagnostics Product and Services

 

2.7.5 Ortho Clinical Diagnostics Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.8 Siemens Healthineers

 

2.8.1 Siemens Healthineers Details

 

2.8.2 Siemens Healthineers Major Business and Total Revenue (Financial Highlights) Analysis

 

2.8.3 Siemens Healthineers SWOT Analysis

 

2.8.4 Siemens Healthineers Product and Services

 

2.8.5 Siemens Healthineers Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.9 Thermo Fisher Scientific

 

2.9.1 Thermo Fisher Scientific Details

 

2.9.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis

 

2.9.3 Thermo Fisher Scientific SWOT Analysis

 

2.9.4 Thermo Fisher Scientific Product and Services

 

2.9.5 Thermo Fisher Scientific Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.10 Diasorin

 

2.10.1 Diasorin Details

 

2.10.2 Diasorin Major Business and Total Revenue (Financial Highlights) Analysis

 

2.10.3 Diasorin SWOT Analysis

 

2.10.4 Diasorin Product and Services

 

2.10.5 Diasorin Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

2.11 GE Healthcare

 

2.11.1 GE Healthcare Details

 

2.11.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis

 

2.11.3 GE Healthcare SWOT Analysis

 

2.11.4 GE Healthcare Product and Services

 

2.11.5 GE Healthcare Blood Screening Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

 

3 Sales, Revenue and Market Share by Manufacturer

 

3.1 Global Blood Screening Sales and Market Share by Manufacturer (2018-2019)

 

3.2 Global Blood Screening Revenue and Market Share by Manufacturer (2018-2019)

 

3.3 Market Concentration Rate

 

3.3.1 Top 3 Blood Screening Manufacturer Market Share in 2019

 

3.3.2 Top 6 Blood Screening Manufacturer Market Share in 2019

 

3.4 Market Competition Trend

 

4 Global Market Analysis by Regions

 

4.1 Global Blood Screening Sales, Revenue and Market Share by Regions

 

4.1.1 Global Blood Screening Sales and Market Share by Regions (2017-2020)

 

4.1.2 Global Blood Screening Revenue and Market Share by Regions (2017-2020)

 

4.2 North America Blood Screening Sales and Growth Rate (2017-2020)

 

4.3 Europe Blood Screening Sales and Growth Rate (2017-2020)

 

4.4 Asia-Pacific Blood Screening Sales and Growth Rate (2017-2020)

 

4.5 South America Blood Screening Sales and Growth Rate (2017-2020)

 

4.6 Middle East and Africa Blood Screening Sales and Growth Rate (2017-2020)

 

5 North America by Country

 

5.1 North America Blood Screening Sales, Revenue and Market Share by Country

 

5.1.1 North America Blood Screening Sales and Market Share by Country (2017-2020)

 

5.1.2 North America Blood Screening Revenue and Market Share by Country (2017-2020)

 

5.2 United States Blood Screening Sales and Growth Rate (2017-2020)

 

5.3 Canada Blood Screening Sales and Growth Rate (2017-2020)

 

5.4 Mexico Blood Screening Sales and Growth Rate (2017-2020)

 

6 Europe by Country

 

6.1 Europe Blood Screening Sales, Revenue and Market Share by Country

 

6.1.1 Europe Blood Screening Sales and Market Share by Country (2017-2020)

 

6.1.2 Europe Blood Screening Revenue and Market Share by Country (2017-2020)

 

6.2 Germany Blood Screening Sales and Growth Rate (2017-2020)

 

6.3 UK Blood Screening Sales and Growth Rate (2017-2020)

 

6.4 France Blood Screening Sales and Growth Rate (2017-2020)

 

6.5 Russia Blood Screening Sales and Growth Rate (2017-2020)

 

6.6 Italy Blood Screening Sales and Growth Rate (2017-2020)

 

7 Asia-Pacific by Regions

 

7.1 Asia-Pacific Blood Screening Sales, Revenue and Market Share by Regions

 

7.1.1 Asia-Pacific Blood Screening Sales and Market Share by Regions (2017-2020)

 

7.1.2 Asia-Pacific Blood Screening Revenue and Market Share by Regions (2017-2020)

 

7.2 China Blood Screening Sales and Growth Rate (2017-2020)

 

7.3 Japan Blood Screening Sales and Growth Rate (2017-2020)

 

7.4 Korea Blood Screening Sales and Growth Rate (2017-2020)

 

7.5 India Blood Screening Sales and Growth Rate (2017-2020)

 

7.6 Southeast Asia Blood Screening Sales and Growth Rate (2017-2020)

 

7.7 Australia Blood Screening Sales and Growth Rate (2017-2020)

 

8 South America by Country

 

8.1 South America Blood Screening Sales, Revenue and Market Share by Country

 

8.1.1 South America Blood Screening Sales and Market Share by Country (2017-2020)

 

8.1.2 South America Blood Screening Revenue and Market Share by Country (2017-2020)

 

8.2 Brazil Blood Screening Sales and Growth Rate (2017-2020)

 

8.3 Argentina Blood Screening Sales and Growth Rate (2017-2020)

 

9 Middle East & Africa by Countries

 

9.1 Middle East & Africa Blood Screening Sales, Revenue and Market Share by Country

 

9.1.1 Middle East & Africa Blood Screening Sales and Market Share by Country (2017-2020)

 

9.1.2 Middle East & Africa Blood Screening Revenue and Market Share by Country (2017-2020)

 

9.2 Saudi Arabia Blood Screening Sales and Growth Rate (2017-2020)

 

9.3 Turkey Blood Screening Sales and Growth Rate (2017-2020)

 

9.4 Egypt Blood Screening Sales and Growth Rate (2017-2020)

 

9.5 South Africa Blood Screening Sales and Growth Rate (2017-2020)

 

10 Market Segment by Product & Service

 

10.1 Global Blood Screening Sales and Market Share by Product & Service (2017-2020)

 

10.2 Global Blood Screening Revenue and Market Share by Product & Service(2017-2020)

 

10.3 Global Blood Screening Price by Product & Service (2017-2020)

 

11 Global Blood Screening Market Segment by Technology

 

11.1 Global Blood Screening Sales Market Share by Technology (2017-2020)

 

11.2 Global Blood Screening Revenue Market Share by Technology (2017-2020)

 

11.3 Global Blood Screening Price by Technology (2017-2020)                                                 

 12 Global Blood Screening Market Segment by End User

 

12.1 Global Blood Screening Sales Market Share by End User (2017-2020)

 

12.2 Global Blood Screening Revenue Market Share by End User (2017-2020)

 

12.3 Global Blood Screening Price by End User (2017-2020)                                                                             

 

13 Market Forecast

 

13.1 Global Blood Screening Sales, Revenue and Growth Rate (2021-2024)

 

13.2 Blood Screening Market Forecast by Regions (2021-2024)

 

13.2.1 North America Blood Screening Market Forecast (2021-2024)

 

13.2.2 Europe Blood Screening Market Forecast (2021-2024)

 

13.2.3 Asia-Pacific Blood Screening Market Forecast (2021-2024)

 

13.2.4 South America Blood Screening Market Forecast (2021-2024)

 

13.2.5 Middle East & Africa Blood Screening Market Forecast (2021-2024)

 

13.3 Blood Screening Market Forecast by Product & Services (2021-2024)

 

13.3.1 Global Blood Screening Sales Forecast by Product & Services (2021-2024)

 

13.3.2 Global Blood Screening Market Share Forecast by Product & Services (2021-2024)

 

13.4 Blood Screening Market Forecast by Technology (2021-2024)

 

13.4.1 Global Blood Screening Sales Forecast by Technology (2021-2024)

 

13.4.2 Global Blood Screening Market Share Forecast by Technology (2021-2024)  

 

13.4 Blood Screening Market Forecast by End User (2021-2024)

 

13.4.1 Global Blood Screening Sales Forecast by End User (2021-2024)

 

13.4.2 Global Blood Screening Market Share Forecast by End User (2021-2024)                                

 

14 Sales Channel, Distributors, Traders and Dealers

 

14.1 Sales Channel

 

14.1.1 Direct Marketing

 

14.1.2 Indirect Marketing

 

14.2 Distributors, Traders and Dealers

 

15 Research Findings and Conclusion

 

16 Appendix

 

16.1 Methodology

 

16.2 Data Source

 

16.3 Disclaimer

 

16.4 About US

 

 

 

Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets